ARTMS Inc. a global leader in developing technology that transforms the production of the world’s most-used diagnostic imaging isotopes, today announced that it has raised US$19 million in a Series A financing. The investment was led by New York based Deerfield Management Company with continued investment from Vancouver based seed investor GHS Fund (Quark Venture LP and GF Securities). “We are thrilled to have this significant investment with such knowledgeable,…
Read More
The Canadian Nutrition Society 2020 (CNS) meeting scheduled for May 4-7, 2020 was not held in Edmonton as planned. Instead, the CNS held four days of online sessions including their annual trainee poster and infographic competition. Congratulations to the CNS organizing committee for their success bringing together Canadian nutrition researchers from coast to coast during uncertain times. Congratulations to BC…
Read More
Pseudomonas aeruginosa is a motile species that initiates swarming motility in response to specific environmental cues, i.e., a semisolid surface with amino acids as a nitrogen source (relevant to the human lung). Swarming is an intricately regulated process, but to date posttranscriptional regulation has not been extensively investigated. Small noncoding RNAs (sRNAs) are hypothesized to play posttranscriptional regulatory roles, largely through…
Read More
Four faculty members and two graduate students are recognized with the 2019-2020 Killam Awards for their outstanding teaching, research and service to the community. As one of six Killam institutions, UBC offers yearly awards from the Killam Endowment Fund to faculty and teaching assistants. Killam Teaching Prize The Killam Teaching Prize is awarded annually to faculty nominated by students, colleagues and alumni…
Read More
Building off the discovery of an enzyme called integrin-linked kinase (ILK) made by BC Cancer distinguished scientist Dr. Shoukat Dedhar 24 years ago, BC Cancer’s Drs. Xiaoyan Jiang and Shoukat Dedhar have made a significant advancement in understanding the role of this enzyme in blood cancers. In a study published today in Cell Stem Cell, Dr. Katharina Rothe from Dr.…
Read More
The authors found that there is a ribosomal RNA hyper-modification called 1-methyl-3-α-amino-α-carboxyl-propyl pseudouridine (macpΨ) that is perturbed in human cancers. The modification is 1.5 billion years conserved (all eukaryotes have it, no exceptions). 45% of colorectal cancer (CRC) tumours have a partial loss of this modification, and the same phenotype is seen in >22 distinct types of cancers.
Read More
Between May 4-8, 2020, the UBC Centre for Heart Lung Innovation (HLI) was proud to host the first-ever Faculty of Medicine Career Week virtually via Zoom Webinar. Despite ongoing physical distancing measures due to the COVID-19 pandemic, the HLI Trainee Association, supported by Education Director Dr. Scott Tebbutt and Research & Industry Partnerships Manager Dr. Tony Yang, organized an exciting program of…
Read More
Opinion: In times like these it’s essential to keep our teams of research scientists and engineers engaged and supported. We all hope for a COVID-19 vaccine that will save lives and allow for a full economic and social recovery. Even in this welcome scenario, the economic reactivation and return to community life will be challenging. Canada most likely needs to…
Read More
From life-saving cancer treatments to clean technologies that protect our environment, thousands of research staff in Canada are driving discoveries and innovations that support our well-being and our economy. When we need them the most, many members of Canada’s academic research community have been forced to temporarily suspend their work due to COVID-19. To ensure they can keep their jobs,…
Read More